3 Dow Stocks Shining Bright in 2025: IBM, Amgen, Coca-Cola

Three Dow stocks stand out in 2025 with strong gains. IBM leads at nearly 20%, followed by Amgen at 16%, and Coca-Cola at 15%. Investors look to capitalize on their strong performances.

Date: 25-02-2025

AI Rating: 7

Earnings and Revenue Insights: The report details how three Dow stocks are performing exceptionally well in 2025. IBM has achieved nearly a 20% increase in shares, attributed to its significant revenue of $17.6 billion generated in the fourth quarter of 2024. Amgen is also performing well, with shares up 16% year-to-date, propelled by significant free cash flow growth, skyrocketing to $10.4 billion from $7.4 billion in the previous year. Coca-Cola follows closely with nearly 15% gain, outperforming revenue and earnings estimates for its fourth quarter.

Free Cash Flow (FCF): Amgen's free cash flow has shown positive movement, indicating robust operational performance and potential for further investments or returns to shareholders.

Market Position: IBM is focusing on leveraging its AI capabilities despite competition from new entrants, suggesting a strategic pivot that could enhance its market dominance. The response to DeepSeek’s low-cost AI models highlights IBM's adaptability. Amgen's FDA approval for a new cancer treatment demonstrates significant growth potential, tapping into unmet medical needs.

Dividend Strategies: Coca-Cola's ongoing success is bolstered by its consistent dividend hikes, marking its 63rd consecutive annual dividend increase, which is attractive for income-focused investors.

Stocks: IBM AMGN KO